AGIOS PHARMACEUTICALS, INC. Other Liabilities, Noncurrent in USD from Q4 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Agios Pharmaceuticals, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2012 to Q3 2025.
  • Agios Pharmaceuticals, Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2025 was $90K, a 92.2% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $90K -$1.07M -92.2% Sep 30, 2025 10-Q 2025-10-30
Q2 2025 $101K -$1.06M -91.3% Jun 30, 2025 10-Q 2025-07-31
Q1 2025 $880K -$276K -23.9% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $880K -$276K -23.9% Dec 31, 2024 10-Q 2025-10-30
Q3 2024 $1.16M $0 0% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.16M $0 0% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.16M -$157K -12% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.16M -$2.12M -64.7% Dec 31, 2023 10-K 2025-02-13
Q3 2023 $1.16M +$101K +9.57% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.16M +$101K +9.57% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.31M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $3.28M +$3.28M Dec 31, 2022 10-K 2024-02-15
Q3 2022 $1.06M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.06M Jun 30, 2022 10-Q 2022-08-04
Q4 2021 $0 Dec 31, 2021 10-K 2023-02-23
Q2 2014 $2K Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $3K Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $6K -$352K -98.3% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $262K Sep 30, 2013 10-Q 2013-11-07
Q4 2012 $358K Dec 31, 2012 10-Q 2013-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.